한글목차

건선성 관절염 치료 시장 규모는 최근 몇 년간 크게 성장했습니다. 2025년 131억 7,000만 달러에서 2026년에는 143억 6,000만 달러에 이르고, CAGR 9.0%의 성장이 전망되고 있습니다. 지난 몇 년간의 성장은 첨단 치료법의 제한적인 가용성, 기존의 비스테로이드성 항염증제(NSAIDs) 및 질병 조절 항류마티스제(DMARDs)에 대한 의존도, 건선성 관절염의 유병률 증가, 환자 인식 증가, 병원 및 소매 약국 인프라의 확장에 기인하는 것으로 보입니다.

건선성 관절염 치료 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 206억 2,000만 달러에 이르고, CAGR은 9.5%를 나타낼 전망입니다. 예측 기간 동안의 성장 요인으로는 인터루킨 억제제 및 JAK 억제제 개발, 생물학적 제제 도입 확대, 개인 맞춤형 의료 접근법의 발전, 만성질환 관리에 있어 원격의료의 확산, 건선성 관절염 치료에 대한 정부 및 보험 지원 강화 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 생물학적 제제 및 표적형 합성 DMARD의 채택 증가, 건선성 관절염의 조기 진단 및 관리에 대한 인식 증가, 관절 및 피부 증상에 대한 맞춤 치료 접근법 확대, 병원 및 전문 약국 유통 채널 확대, 건선성 관절염 환자를 위한 원격 의료 및 원격 모니터링의 통합 등이 있습니다. 건선성 관절염 환자를 위한 원격 의료 및 원격 모니터링의 통합 등을 들 수 있습니다.

의료비 지출 증가는 향후 몇 년 동안 건선성 관절염 치료제 시장의 성장을 뒷받침할 것으로 예측됩니다. 헬스케어 지출은 국가, 지역 또는 의료 시스템 내에서 의료 서비스, 제품, 프로그램을 제공하기 위해 투입되는 재원을 의미합니다. 의료비 지출 증가는 의사 진료, 임상 검사, 영상 진단에 대한 자금 지원을 통해 진단 과정을 촉진합니다. 건선성 관절염(PsA) 환자는 일반적으로 진단 확정, 관절 병변의 중증도 평가, 관련 동반 질환을 확인하기 위해 정밀 검사를 받게 됩니다. 예를 들어, 미국 메디케어 및 메디케이드 서비스 센터(미국의 메디케어 및 메디케이드 프로그램을 감독하는 기관)에 따르면, 2024년 12월 기준 2023년 미국 의료비 지출은 7.5% 증가하여 4조 9,000억 달러(1인당 약 1만 4,570달러)에 달할 것으로 예상하고 있습니다. 에 도달했습니다. 그 결과, 의료비 지출 증가가 건선성 관절염 치료제 시장의 성장에 기여하고 있습니다.

건선성 관절염 치료제 시장에서 사업을 전개하는 주요 기업들은 시장에서의 입지를 강화하고 수익성을 개선하기 위해 코센틱스(Cosentyx)와 같은 새로운 치료제의 승인을 추진하고 있습니다. 코센틱스는 비방사선학적 축성 척추관절염, 심상성 건선, 건선성 관절염, 강직성 척추염, 부착부위염 관련 관절염 등 자가면역질환 치료에 사용되는 의약품입니다. 예를 들어, 2023년 10월 스위스에 본사를 둔 제약회사 노바티스는 미국 식품의약국(FDA)의 코센틱스의 승인을 발표했습니다. 코센틱스는 인간 인터루킨-17A 길항제로 IL-17A 단백질의 활성을 억제하여 부종, 통증, 피부 자극 등의 잠재적 부작용을 감소시키는 작용을 합니다. 임상시험 결과, 코센틱스는 단 3주 만에 건선성 관절염의 증상 완화를 시작하고 관절통, 압통, 요통, 피부 관련 증상에 대처할 수 있는 것으로 나타났습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Psoriatic arthritis treatment refers to the use of therapies or medications aimed at preventing or reducing a chronic inflammatory condition affecting the joints and the sites where tendons and ligaments attach to bones, known as entheses. These treatments focus on managing skin involvement while alleviating joint pain and improving functional ability.

The primary drug classes used in psoriatic arthritis treatment include nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs), biologics, and others. Biologics are medications that are derived from or contain components of living organisms. The various routes of administration include oral, parenteral, and topical, and these treatments are distributed through channels such as hospital pharmacies, retail pharmacies, and online pharmacies.

Tariffs have impacted the psoriatic arthritis treatment market by raising the cost of imported biologics, targeted synthetic dmards, and specialty medications. Segments such as interleukin inhibitors and jak inhibitors are particularly affected, with North America and Europe being most sensitive due to their reliance on imports. This has led to higher treatment costs and potential delays in patient access. On the positive side, tariffs have encouraged domestic manufacturing, local R&D investment, and innovation in cost-effective psoriatic arthritis therapies.

The psoriatic arthritis treatment market research report is one of a series of new reports from The Business Research Company that provides psoriatic arthritis treatment market statistics, including psoriatic arthritis treatment industry global market size, regional shares, competitors with a psoriatic arthritis treatment market share, detailed psoriatic arthritis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the psoriatic arthritis treatment industry. This psoriatic arthritis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The psoriatic arthritis treatment market size has grown strongly in recent years. It will grow from $13.17 billion in 2025 to $14.36 billion in 2026 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to limited availability of advanced therapies, reliance on conventional nsaids and dmards, increasing prevalence of psoriatic arthritis, growing patient awareness, expansion of hospital and retail pharmacy infrastructure.

The psoriatic arthritis treatment market size is expected to see strong growth in the next few years. It will grow to $20.62 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to development of interleukin inhibitors and jak inhibitors, increasing adoption of biologics, growth of personalized medicine approaches, rising telemedicine adoption for chronic disease management, increasing government and insurance support for psoriatic arthritis treatment. Major trends in the forecast period include rising adoption of biologics and targeted synthetic dmards, increased awareness of early diagnosis and management of psoriatic arthritis, growth in personalized treatment approaches for joint and skin symptoms, expansion of hospital and specialty pharmacy distribution channels, integration of telemedicine and remote monitoring for psoriatic arthritis patients.

The rise in healthcare spending is expected to support the expansion of the psoriatic arthritis treatment market in the coming years. Healthcare spending, also referred to as healthcare expenditure, represents the financial resources devoted to delivering healthcare services, products, and programs within a country, region, or healthcare system. Increased healthcare spending facilitates the diagnostic process by funding physician visits, laboratory testing, and imaging procedures. Patients with psoriatic arthritis (PsA) typically undergo thorough evaluations to confirm the diagnosis, assess the severity of joint involvement, and identify any related comorbid conditions. For example, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency that oversees the Medicare and Medicaid programs, U.S. healthcare expenditures rose by 7.5% in 2023, reaching $4.9 trillion, or approximately $14,570 per person. As a result, rising healthcare expenditure is contributing to the growth of the psoriatic arthritis treatment market.

Key companies operating in the psoriatic arthritis treatment market are obtaining approvals for new therapies, such as Cosentyx, to strengthen their market presence and improve profitability. Cosentyx is a medication used in the treatment of autoimmune conditions, including non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and enthesitis-related arthritis. For instance, in October 2023, Novartis, a Switzerland-based pharmaceutical company, announced that the Food and Drug Administration had approved Cosentyx. Cosentyx is a human interleukin-17A antagonist that works by inhibiting the activity of the IL-17A protein, thereby reducing potential side effects such as swelling, pain, and skin irritation. Clinical evidence shows that Cosentyx can begin relieving psoriatic arthritis symptoms within as little as three weeks, addressing joint pain and tenderness, back pain, and skin-related symptoms.

In February 2023, Takeda Pharmaceutical Company, a Japan-based pharmaceutical firm, acquired Nimbus Therapeutics for an undisclosed amount. This acquisition is expected to strengthen Takeda Pharmaceutical's position in the psoriatic arthritis treatment market and expand its product portfolio. Nimbus Therapeutics is a US-based biotechnology company that focuses on developing therapies for psoriatic arthritis.

Major companies operating in the psoriatic arthritis treatment market are AbbVie Inc., Amgen Astellas BioPharma K.K., Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Celgene Corporation, Novartis International AG, Eli Lilly and Company, Pfizer Inc., Merck & Co. Inc., AstraZeneca plc, Sanofi SA, Otsuka Pharmaceutical Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Bayer AG, Eisai Inc., Janssen Pharmaceuticals Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Chugai Pharmaceutical Co. Ltd., Kyowa Kirin Co. Ltd.

North America was the largest region in the psoriatic arthritis treatment market in 2025. The regions covered in the psoriatic arthritis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the psoriatic arthritis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The psoriatic arthritis treatment market includes revenues earned by entities by reducing pain and swelling and controlling inflammation and pain. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Psoriatic Arthritis Treatment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses psoriatic arthritis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for psoriatic arthritis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The psoriatic arthritis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDS); Disease-Modifying Anti-Rheumatic Drugs (DMARDS); Biologics; Other Drug Classes
• 2) By Route Of Administration: Oral; Parenteral; Topical
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Traditional NSAIDs; COX-2 Inhibitors
• 2) By Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Conventional DMARDs; Targeted Synthetic DMARDs
• 3) By Biologics: Tumor Necrosis Factor (TNF) Inhibitors; Interleukin Inhibitors; Other Biologics
• 4) By Other Drug Classes: Corticosteroids; Topical Treatments; Janus Kinase (JAK) Inhibitors
• Companies Mentioned: AbbVie Inc.; Amgen Astellas BioPharma K.K.; Johnson & Johnson Services Inc.; Bristol-Myers Squibb Company; Celgene Corporation; Novartis International AG; Eli Lilly and Company; Pfizer Inc.; Merck & Co. Inc.; AstraZeneca plc; Sanofi SA; Otsuka Pharmaceutical Co. Ltd.; Sumitomo Dainippon Pharma Co. Ltd.; Bayer AG; Eisai Inc.; Janssen Pharmaceuticals Inc.; Gilead Sciences Inc.; GlaxoSmithKline plc; Regeneron Pharmaceuticals Inc.; Sun Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Company Limited; Teva Pharmaceutical Industries Ltd.; Chugai Pharmaceutical Co. Ltd.; Kyowa Kirin Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Psoriatic Arthritis Treatment Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Psoriatic Arthritis Treatment Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Psoriatic Arthritis Treatment Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Psoriatic Arthritis Treatment Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Artificial Intelligence & Autonomous Intelligence
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Rising Adoption Of Biologics And Targeted Synthetic DMARDs
  • 4.2.2 Increased Awareness Of Early Diagnosis And Management Of Psoriatic Arthritis
  • 4.2.3 Growth In Personalized Treatment Approaches For Joint And Skin Symptoms
  • 4.2.4 Expansion Of Hospital And Specialty Pharmacy Distribution Channels
  • 4.2.5 Integration Of Telemedicine And Remote Monitoring For Psoriatic Arthritis Patients

5. Psoriatic Arthritis Treatment Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Specialty Clinics
• 5.3 Retail Pharmacies
• 5.4 Online Pharmacies
• 5.5 Rheumatology Centers

6. Psoriatic Arthritis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Psoriatic Arthritis Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Psoriatic Arthritis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Psoriatic Arthritis Treatment Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Psoriatic Arthritis Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Psoriatic Arthritis Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Psoriatic Arthritis Treatment Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Psoriatic Arthritis Treatment Market Segmentation

• 9.1. Global Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Nonsteroidal Anti-Inflammatory Drugs (NSAIDS), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biologics, Other Drug Classes
• 9.2. Global Psoriatic Arthritis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral, Parenteral, Topical
• 9.3. Global Psoriatic Arthritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
• 9.4. Global Psoriatic Arthritis Treatment Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Traditional NSAIDs, COX-2 Inhibitors
• 9.5. Global Psoriatic Arthritis Treatment Market, Sub-Segmentation Of Disease-Modifying Anti-Rheumatic Drugs (DMARDs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Conventional DMARDs, Targeted Synthetic DMARDs
• 9.6. Global Psoriatic Arthritis Treatment Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Other Biologics
• 9.7. Global Psoriatic Arthritis Treatment Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Corticosteroids, Topical Treatments, Janus Kinase (JAK) Inhibitors

10. Psoriatic Arthritis Treatment Market Regional And Country Analysis

• 10.1. Global Psoriatic Arthritis Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Psoriatic Arthritis Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Psoriatic Arthritis Treatment Market

• 11.1. Asia-Pacific Psoriatic Arthritis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Psoriatic Arthritis Treatment Market

• 12.1. China Psoriatic Arthritis Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Psoriatic Arthritis Treatment Market

• 13.1. India Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Psoriatic Arthritis Treatment Market

• 14.1. Japan Psoriatic Arthritis Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Psoriatic Arthritis Treatment Market

• 15.1. Australia Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Psoriatic Arthritis Treatment Market

• 16.1. Indonesia Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Psoriatic Arthritis Treatment Market

• 17.1. South Korea Psoriatic Arthritis Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Psoriatic Arthritis Treatment Market

• 18.1. Taiwan Psoriatic Arthritis Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Psoriatic Arthritis Treatment Market

• 19.1. South East Asia Psoriatic Arthritis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Psoriatic Arthritis Treatment Market

• 20.1. Western Europe Psoriatic Arthritis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Psoriatic Arthritis Treatment Market

• 21.1. UK Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Psoriatic Arthritis Treatment Market

• 22.1. Germany Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Psoriatic Arthritis Treatment Market

• 23.1. France Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Psoriatic Arthritis Treatment Market

• 24.1. Italy Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Psoriatic Arthritis Treatment Market

• 25.1. Spain Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Psoriatic Arthritis Treatment Market

• 26.1. Eastern Europe Psoriatic Arthritis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Psoriatic Arthritis Treatment Market

• 27.1. Russia Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Psoriatic Arthritis Treatment Market

• 28.1. North America Psoriatic Arthritis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Psoriatic Arthritis Treatment Market

• 29.1. USA Psoriatic Arthritis Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Psoriatic Arthritis Treatment Market

• 30.1. Canada Psoriatic Arthritis Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Psoriatic Arthritis Treatment Market

• 31.1. South America Psoriatic Arthritis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Psoriatic Arthritis Treatment Market

• 32.1. Brazil Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Psoriatic Arthritis Treatment Market

• 33.1. Middle East Psoriatic Arthritis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Psoriatic Arthritis Treatment Market

• 34.1. Africa Psoriatic Arthritis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Psoriatic Arthritis Treatment Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Psoriatic Arthritis Treatment Market Regulatory and Investment Landscape

36. Psoriatic Arthritis Treatment Market Competitive Landscape And Company Profiles

• 36.1. Psoriatic Arthritis Treatment Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Psoriatic Arthritis Treatment Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Psoriatic Arthritis Treatment Market Company Profiles
  • 36.3.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Amgen Astellas BioPharma K.K. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Celgene Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Psoriatic Arthritis Treatment Market Other Major And Innovative Companies

• Novartis International AG, Eli Lilly and Company, Pfizer Inc., Merck & Co. Inc., AstraZeneca plc, Sanofi SA, Otsuka Pharmaceutical Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Bayer AG, Eisai Inc., Janssen Pharmaceuticals Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd.

38. Global Psoriatic Arthritis Treatment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Psoriatic Arthritis Treatment Market

40. Psoriatic Arthritis Treatment Market High Potential Countries, Segments and Strategies

• 40.1 Psoriatic Arthritis Treatment Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Psoriatic Arthritis Treatment Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Psoriatic Arthritis Treatment Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer